ClinicalTrials.gg
RecruitingNCT07664371Updated Aug 11, 2026

Cryoneurolysis Versus Radiofrequency in Knee Osteoarthritis

An interventional study of Cryoneurolysis and pulsed radiofrequency (RF) in Knee Osteoarthritis, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Osteoarthritis, Knee by Tanta University — 5 open to participants now, 5 under way, none of them phase 3. Osteoarthritis, Knee · Tanta University.

Planned enrollment
12th of 12
30 · median 67
Started
2026
with 3 others
No phase
10 of 12
4 open now
Registered
9th of 12
by date

Among the 12 studies in Osteoarthritis, Knee by Tanta University, this one is the 12th largest by planned enrollment, is one of 4 that started in 2026, is one of 10 with no phase, and was the 9th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

5 of the 12 studies in Osteoarthritis, Knee by Tanta University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Osteoarthritis, Knee by Tanta University, or all of them as a file.
02

Study summary

The project will evaluate the effectiveness of Cryoneurolysis versus radiofrequency procedures in adult patients who are resistant to traditional treatment for knee pain. They are a drug-free pain management procedure.

Read the detailed description

The main approach to OA management is pain control. Cryoneurolysis versus radiofrequency in decreasing knee pain.

03

Conditions studied

  • Knee Osteoarthritis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults with a clinical diagnosis of knee OA who suffered from refractory knee pain (patients who had failed conservative medical and physical therapy for 6 months .

Exclusion criteria

Exclusion Criteria:

  1. Patients with OA show improvement in pain after conservative medical and physical therapy.
  2. Patients evaluated by an orthopedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA.
  3. Patients with allergies to local anesthetics.
  4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation.
  5. Patients with knee tumors.
  6. Patients with acute infections.
  7. Patients with implanted cardiac devices.
  8. Pregnant patients.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Relapsed and refractory

Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Group I will be treated with Cryoneurolysis

    Cryoneurolysis freezes nerves

    Device: Cryoneurolysis

  • Experimental
    Group II will be treated with pulsed radiofrequency (RF)

    radiofrequency (RF) uses electric pulses

    Device: pulsed radiofrequency (RF)

  • Experimental
    Group III will be treated with cooled radiofrequency (RF)

    uses cooled radiofrequency energy to deactivate pain-causing nerves

    Device: cooled radiofrequency

Interventions

  • DeviceCryoneurolysis

    Cryoneurolysis freezes nerves

  • Devicepulsed radiofrequency (RF)

    radiofrequency (RF) uses electric pulses

  • Devicecooled radiofrequency

    uses cooled radiofrequency energy to deactivate pain-causing nerves

06

What researchers measure

Primary outcomes

  1. Change in visual analogue scale after intervention

    Decrement (clinical improvement) in visual analogue scale (VAS) immediately after intervention. The participant's knee discomfort was measured using a VAS. Participants were asked to score their level of pain on a 100-mm horizontal line, ranging from 0 to 100.

    Time frame: immediately after intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Plan to Share IPD: "Yes" Plan Description: "Data obtained through this study may be provided to qualified researchers with academic interest in scapular dyskinesis. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e., a material transfer agreement) are prerequisites to the sharing of data with the requesting party. Results will be published by the investigators in academic journal.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Access criteria: Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 5 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2026
First posted
Jun 24, 2026
StartActual
Jun 10, 2026
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2026
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07664371
Lead sponsor
Tanta University
Responsible party
Aliaa Mamdouh Abdelaziz Farag (Lecturer, Tanta University) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 10, 2026
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Aug 11, 2026

Study contacts

Aliaa Mamdouh Abdelaziz Farag, MD
Contact
aliaa.mamdouh@med.tanta.edu.eg
+201069468486

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion